SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: Micawber who wrote (2723)10/11/1999 3:19:00 PM
From: tuck  Respond to of 4676
 
Brian,

Looking forward to the action, as I am indeed a trader in the sense that I tend to write calls against stock that I own.

Stock is showing a little late day strength.

Cheers, Tuck



To: Micawber who wrote (2723)10/11/1999 3:28:00 PM
From: bob oserin  Read Replies (2) | Respond to of 4676
 
Look at Worth blurb. McCament still pushing ISIP up to $20.
Looking for 2-3 times increase over 12-18 mos. Means $30-$40 tag.
If FDA approval on Crohns drug, time cap could be moved up.
Mfrg facilities being set up for use on an " UNKNOWN PRODUCT." I don't believe it!! McCamant may have the P111 leak and can see the
time horizon we can't. MHO.

BOB O


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News